Personalized medicine, documented.
RonanRx coordinates doctor-controlled compounded therapy under section 503A. Every order carries 1 patient-specific prescription, passes 8 code-enforced release gates, and is signed by 2 licensed authorities, a physician and a pharmacist. 100 percent of state transitions are written to an audit record. Nothing here is sold off a shelf: a doctor decides, a pharmacist releases, and this document explains the rest.
Free to start. Nothing is prescribed unless a physician decides it is right for you.
What this is, in plain terms.
You text us. A physician reviews your health history and either writes a prescription for you by name or tells you no. If yes, a licensed compounding pharmacy prepares your medication for your body and your dose, and a pharmacist checks the work before anything ships.
That is the whole model. There is no cart, no subscription tier that skips the doctor, and no vial that exists before your prescription does. The current program centers on personalized GLP-1 care, including compounded semaglutide, prepared one patient at a time. Compounded drugs are not FDA-approved; they are prepared under 503A on a doctor's patient-specific prescription.
If a physician decides this therapy is not right for you, the process stops there, and you will be told why.
The same medicine, twice described.
We write every clinical brief in two registers, side by side. Your patients read the first. You read the second. Neither is dumbed down for the other.
In brief, for the patient
Semaglutide is a once-weekly injection that works like a natural gut hormone called GLP-1. It lowers blood sugar and reduces appetite, and your dose is prepared for your body, not a standard curve.
PLAIN LANGUAGE · SECOND PERSONFor clinicians
A 94 percent-homologous GLP-1 analogue with two structural modifications: an Aib-2 substitution that resists DPP-4 cleavage, and a C-18 fatty diacid chain enabling albumin binding, supporting once-weekly dosing with patient-specific titration. Prescribers retain full authority over selection, dose, and discontinuation; the platform cannot advance an order past a physician who declines.
FULL TECHNICAL PRECISION · UNSIMPLIFIEDPhysicians who prescribe through RonanRx remain their patients' prescribers. There is no drug margin, no referral bounty, and no incentive attached to any prescribing decision.
Preparations.
Every preparation below requires a valid patient-specific prescription from a licensed physician. Availability is a clinical decision, never a checkout option.
| Substance | Class | Form | Status |
|---|---|---|---|
| Semaglutide | GLP-1 ANALOGUE | Injectable, once weekly | Available with valid Rx |
| Semaglutide with cyanocobalamin (B12) | GLP-1 ANALOGUE + ADJUNCT | Injectable, once weekly | Available with valid Rx |
| Tirzepatide | GIP/GLP-1 CO-AGONIST | Injectable, once weekly | Subject to evolving FDA review |
| Adjunct micronutrient preparations | SUPPORTIVE | Per prescription | Available with valid Rx |
Compounded drugs are not FDA-approved. Preparations are compounded under 503A on a doctor's patient-specific prescription, and availability reflects current regulatory posture, which can change.
Who decides what.
- The doctor decides.
- Clinical authority stays with a licensed physician. No RonanRx employee can prescribe, and the platform cannot move an order past a physician who says no. GATE · DOCTOR_APPROVES
- The pharmacist releases.
- Nothing ships on software's say-so. Release requires a licensed pharmacist's verification of the prescription, the formulation, and the ingredient lot record. GATE · QA_RELEASE
- RonanRx operates the rest.
- We coordinate intake, records, compounding logistics, and refills. The judgment calls belong to licensed humans, and every handoff between them is written down. EVERY TRANSITION · AUDIT RECORD
code-enforced gates, each one fails closed
licensed authorities per order, MD and RPh, by name
patient-specific Rx, always, never batch
of state transitions written to the audit record
OPERATIONAL VOLUME METRICS PUBLISH HERE AFTER EXTERNAL AUDIT.
This site is not a storefront.1
Where your medicine can come from.
The same molecule can reach you three ways. The differences are structural, and they are checkable.
| Criterion | RonanRx 503A, patient-specific | Gray-market vials "research use" sellers | One-size brand pens fixed-dose retail |
|---|---|---|---|
| Patient-specific prescription required | Yes, always | No | Rx required, not compounded |
| Licensed pharmacist release | Yes, fail-closed | No | Yes |
| Ingredient lots traceable to your vial | Yes, lot-level | Unverifiable | Batch-level only |
| Physician stays your prescriber | Yes, for the whole course | No physician | Varies by seller |
| Source identity verified before use | Yes, substance matched to lot | Unknown | Yes |
| Dose prepared for your body | Yes, per prescription | Self-measured | Fixed dose steps |
Compounded drugs are not FDA-approved, and compounded versions should not be evaluated using branded-drug trial data. This table compares structure and accountability, not clinical outcomes.
The caution, set in full.
Most sites bury this paragraph at the bottom of the page in small gray type. We think it belongs here, in the body of the document, at reading size.
Compounded drugs are not FDA-approved. We compound under 503A on a doctor's patient-specific prescription. Per FDA guidance, compounded versions of an FDA-approved drug are generally restricted to documented patient-specific clinical need.
RonanRx is not a pharmacy. Prescriptions are filled by Elite Care Pharmacy LLC, a separately licensed Texas pharmacy owned by RonanRx, Inc. A physician and a pharmacist, each licensed and each named, stand behind every order this platform coordinates.
You only move forward if a physician agrees it is right for you.
This is a doctor-prescribed therapy, not a direct-to-consumer product. The text intake is free, and if personalized care is not right for you, a physician will say so.